What is Gallavardin’s phenomenon and what are the recommended diagnostic steps and management for patients with calcific aortic stenosis presenting with this finding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gallavardin's Phenomenon in Calcific Aortic Stenosis

Definition and Clinical Significance

Gallavardin's phenomenon is a specific auscultatory finding in calcific aortic stenosis where the high-frequency components of the systolic ejection murmur radiate to the cardiac apex and may be mistaken for mitral regurgitation, potentially leading to diagnostic confusion and delayed recognition of severe aortic stenosis. 1, 2

The phenomenon occurs because:

  • The harsh, low-frequency components of the aortic stenosis murmur are best heard at the right upper sternal border (second right intercostal space) and radiate to the carotids 2
  • The high-frequency, musical components selectively transmit to the apex, creating a separate-sounding murmur that mimics mitral regurgitation 1, 2
  • This apical component may be softer and more blowing in quality, further resembling mitral regurgitation 1

Key Diagnostic Clues to Differentiate from Mitral Regurgitation

Physical Examination Features That Confirm Aortic Stenosis

  • Absent or markedly diminished A2 component of the second heart sound – this finding is highly specific for severe aortic stenosis and should immediately trigger echocardiography 1, 2
  • Paradoxical (reversed) splitting of S2 – the sound is single on inspiration but splits on expiration, indicating severe disease 2
  • Pulsus parvus et tardus – delayed, diminished carotid upstroke with a positive likelihood ratio of 2.8–130 for severe stenosis, though this may be masked in elderly patients with arterial stiffening 1, 2
  • Presence of S4 gallop – correlates with severe obstruction and left ventricular hypertrophy 2
  • Palpable thrill at the right upper sternal border – indicates significant turbulent flow across the stenotic valve 2

Dynamic Auscultation Maneuvers

  • Valsalva maneuver or standing decreases the intensity of both the basal and apical components of the aortic stenosis murmur, whereas mitral regurgitation remains relatively unchanged 2
  • Squatting markedly augments both components by increasing preload and afterload 2
  • Post-premature ventricular contraction transiently increases pulse pressure and intensifies the murmur 2

Critical Pitfalls to Avoid

  • Do not assume that a prominent apical murmur excludes aortic stenosis – Gallavardin's phenomenon can make the apical component louder than the basal murmur in some patients 1, 2
  • A faint or absent murmur at the base does not exclude severe aortic stenosis, especially in elderly patients or those with low cardiac output states such as heart failure 1, 2
  • Age-related arterial stiffening can mask the classic pulsus parvus et tardus, reducing diagnostic reliability in older adults 1, 2
  • Murmur intensity does not reliably reflect stenosis severity when cardiac output is compromised 1

Recommended Diagnostic Algorithm

Immediate Echocardiography Indications

Proceed directly to transthoracic echocardiography for:

  • Any systolic murmur (regardless of location or grade) in an elderly patient with exertional dyspnea, syncope, angina, or signs of heart failure 1, 2
  • Any murmur with a soft/absent A2 or paradoxical S2 splitting 2
  • Systolic murmurs graded ≥3/6 2
  • Murmurs that radiate to the neck or back 2
  • Any cardiac murmur with abnormal ECG (left ventricular hypertrophy) or chest radiograph abnormalities 2

Echocardiographic Assessment

The study must evaluate 3, 2, 4:

  • Aortic valve area (AVA) – severe stenosis defined as <1.0 cm² or indexed AVA <0.6 cm²/m² 2, 4
  • Peak aortic valve velocity – severe stenosis defined as ≥4.0 m/s 2, 4
  • Mean transvalvular gradient – severe stenosis defined as ≥40 mm Hg (at normal flow) or ≥50 mm Hg 2, 4
  • Valve morphology and calcification severity – graded as mild, moderate, or severe 3
  • Left ventricular function and wall thickness 3

Low-Flow, Low-Gradient Assessment

When mean gradient <40 mm Hg with AVA ≤1.0 cm² 3, 2, 4:

  • Perform low-dose dobutamine stress echocardiography to differentiate true severe stenosis from pseudo-severe stenosis 3, 2, 4
  • True severe stenosis – valve area remains <1.0 cm² despite increased flow with dobutamine 3, 2, 4
  • Pseudo-severe stenosis – valve area increases >0.2 cm² with augmented flow 3, 2, 4

Management Implications

  • For symptomatic patients with confirmed severe aortic stenosis, aortic valve replacement (surgical or transcatheter) is the only effective treatment and markedly improves survival 3, 5, 6
  • Conservative management of severe symptomatic aortic stenosis carries a 1-year mortality rate up to 50% 6
  • Asymptomatic patients with severe stenosis require close surveillance every 6–12 months with echocardiography and careful symptom assessment 6
  • Patients often under-report symptoms; careful questioning about exercise tolerance and daily activities is essential 1

Ancillary Testing

  • Electrocardiography – left ventricular hypertrophy with or without strain suggests significant stenosis, though absence does not exclude severe disease 2
  • Chest radiography – valve calcification and post-stenotic aortic dilation are common after age 40 2

References

Guideline

Silent Presentation of Severe Aortic Stenosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Aortic Stenosis: Clinical Assessment and Diagnostic Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Aortic Stenosis Diagnostic Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current management of calcific aortic stenosis.

Circulation research, 2013

Related Questions

What are the implications of calcific aortic stenosis with a maximum gradient of 21 millimeters of mercury (mmHg) and a mean gradient of 12 mmHg, accompanied by trivial aortic regurgitation?
What is the management approach for calcified degenerative aortic stenosis in the absence of a bicuspid aortic valve?
What is the best treatment option for a patient with severe calcific aortic stenosis, symptoms such as chest pain, shortness of breath, or fainting, and comorbidities like coronary artery disease, chronic kidney disease, or chronic obstructive pulmonary disease, who is at high risk for surgical aortic valve replacement?
What is the recommended treatment for an elderly man with severe calcific aortic stenosis and an orifice area of 0.6 cm^2?
What is the best course of treatment for an older adult patient with aortic stenosis (AS) experiencing chest pain?
What are the WHO‑classified malignant sex‑cord stromal tumor types of the ovary?
How should I manage hyperkalemia (serum potassium 5.5 mmol/L) in a postoperative colon cancer patient with a colostomy?
How can I differentiate obsessive‑compulsive disorder symptoms from schizophrenia‑related delusions and hallucinations in a 14‑year‑old female with a schizophrenia‑spectrum disorder on aripiprazole, and what is the recommended treatment for comorbid OCD?
What is the concentration in mg per milliliter when 20 mg of retatrutide is diluted in 350 mL of normal saline?
Is a chest X‑ray safe in a woman who is 29 weeks pregnant?
Can percutaneous trans‑hepatic biliary drainage be internalized after 48–72 hours?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.